Literature DB >> 24951933

Exercise ventilatory parameters for the diagnosis of reactive pulmonary hypertension in patients with heart failure.

Hoong Sern Lim1, Maria Theodosiou2.   

Abstract

BACKGROUND: Reactive pulmonary hypertension (PH) in left heart disease is associated with poor prognosis. This study aimed to evaluate the diagnostic utility of exercise ventilatory parameters on cardiopulmonary exercise testing for the diagnosis of reactive PH in patients with heart failure (HF) and reduced ejection fraction.
METHODS: This was a single-center, retrospective analysis of a prospectively collected database of 131 patients with HF who underwent in-hospital assessment for heart transplantation. Pulmonary hemodynamics was assessed by direct cardiac catheterization. Minute ventilation/carbon dioxide production (VE/VCO2) slope, partial pressure of end-tidal carbon dioxide (ETCO2) changes on exercise, oxygen pulse, and exercise oscillatory ventilation were determined from cardiopulmonary exercise testing.
RESULTS: Sixty-one of 131 consecutive patients had reactive PH. VE/VCO2 slope (>41), change in ETCO2 on exercise (<1.2 mm Hg) and exercise oscillatory ventilation were independently associated with reactive PH. These 3 parameters in combination produced 3 possible diagnostic scenarios: (1) if all 3 criteria ("if all") were present, (2) if any 2 of the 3 criteria ("2 of 3") were present, and (3) if any of the criteria ("if any") were present. The corresponding positive/negative likelihood ratios for reactive PH if all 3 criteria were present were 3.73/0.83, if 2 of the 3 criteria were present were 2.19/0.45, and if any of the 3 criteria were present were 1.75/0.11. The posttest probability increased from 46% to 76% ("if all" present) and reduced to 9% (if none of the criteria was present).
CONCLUSION: Ventilatory parameters on cardiopulmonary exercise test are associated with reactive PH in patients with HF. The absence of abnormalities in these 3 ventilatory parameters can effectively exclude reactive PH in patients with HF and poor ejection fraction.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure; pulmonary hypertension

Mesh:

Substances:

Year:  2014        PMID: 24951933     DOI: 10.1016/j.cardfail.2014.06.355

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  10 in total

Review 1.  Altered breathing syndrome in heart failure: newer insights and treatment options.

Authors:  Yasuhiro Tomita; Takatoshi Kasai; Tomohiko Kisaka; Harry B Rossiter; Yasuki Kihara; Karlman Wasserman; Hiroyuki Daida
Journal:  Curr Heart Fail Rep       Date:  2015-04

2.  Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertension.

Authors:  Qin-Hua Zhao; Lan Wang; Bigyan Pudasaini; Rong Jiang; Ping Yuan; Su-Gang Gong; Jian Guo; Qiang Xiao; Hui Liu; Cheng Wu; Zhi-Cheng Jing; Jin-Ming Liu
Journal:  Clin Cardiol       Date:  2016-11-02       Impact factor: 2.882

3.  Submaximal Exercise Pulmonary Gas Exchange in Left Heart Disease Patients With Different Forms of Pulmonary Hypertension.

Authors:  Bryan J Taylor; Michael R Smetana; Robert P Frantz; Bruce D Johnson
Journal:  J Card Fail       Date:  2015-04-14       Impact factor: 5.712

4.  Evaluation of end-tidal CO2 pressure at the anaerobic threshold for detecting and assessing pulmonary hypertension.

Authors:  Akifumi Higashi; Yoshihiro Dohi; Sayuri Yamabe; Hiroki Kinoshita; Yoshiharu Sada; Toshiro Kitagawa; Takayuki Hidaka; Satoshi Kurisu; Hideya Yamamoto; Yuji Yasunobu; Yasuki Kihara
Journal:  Heart Vessels       Date:  2017-05-30       Impact factor: 2.037

5.  Invasive Hemodynamic and Metabolic Evaluation of HFpEF.

Authors:  J Emanuel Finet; Erik H Van Iterson; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-03-26

Review 6.  Exercise Intolerance in Heart Failure: Central Role for the Pulmonary System.

Authors:  Sophie Lalande; Troy J Cross; Manda L Keller-Ross; Norman R Morris; Bruce D Johnson; Bryan J Taylor
Journal:  Exerc Sport Sci Rev       Date:  2020-01       Impact factor: 6.642

7.  The predictive value of minute ventilation versus carbon dioxide production in pulmonary hypertension associated with left heart disease.

Authors:  Xiujun Zhong; Jie Tang; Rong Jiang; Ping Yuan; Qinhua Zhao; Sugang Gong; Jinming Liu; Lan Wang
Journal:  Ann Transl Med       Date:  2021-02

8.  Flavonoids Extraction from Propolis Attenuates Pathological Cardiac Hypertrophy through PI3K/AKT Signaling Pathway.

Authors:  Guang-Wei Sun; Zhi-Dong Qiu; Wei-Nan Wang; Xin Sui; Dian-Jun Sui
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-24       Impact factor: 2.629

9.  Cardiopulmonary Exercise Testing as a Tool for Diagnosing Pulmonary Hypertension in Patients with Dilated Cardiomyopathy.

Authors:  Akihiro Hirashiki; Takahisa Kondo; Takahiro Okumura; Yoshihiro Kamimura; Yoshihisa Nakano; Kenji Fukaya; Akinori Sawamura; Ryota Morimoto; Shiro Adachi; Kyosuke Takeshita; Toyoaki Murohara
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-02-01       Impact factor: 1.468

10.  Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure.

Authors:  Valéry Legris; Bernard Thibault; Jocelyn Dupuis; Michel White; Anita W Asgar; Annik Fortier; Céline Pitre; Nadia Bouabdallaoui; Christine Henri; Eileen O'Meara; Anique Ducharme
Journal:  ESC Heart Fail       Date:  2021-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.